why choose us

First received: June 19, 2023

Clinical Trial: SARS-CoV-2 Antigen RDT Evaluation COVID-19 Antigen Rapid Diagnostic Tests and Algorithms in Low-Prevalence Settings

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Corona Virus Infection

Study Type: OBSERVATIONAL


Official Title: : Performance Assessment of COVID-19 Antigen Rapid Diagnostic Tests and Algorithms in Low-Prevalence Settings

Brief Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting COVID-19 pandemic present important diagnostic challenges.Point-of-care tests that detect SARS-CoV-2 antigen have the potential to allow earlier detection and isolation of confirmed cases compared to PCR-based diagnostic methods, and could be implemented at Ports of Entry (PoE) to screen low-prevalence populations effectively.This study will assess the performance of available antigen Ag-RDTs such as the Panbio and Standard Q SARS-CoV-2…

Read more